menu
    • menu

    Company profile for Sernova

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sernova is a regenerative medicine therapeutics company Developing therapeutics platform technologies to treat chronic diseases through a regenerative medicine approach. Sernova’s primary focus is the development of technologies for the treatment of patients with insulin-dependent (T1) diabetes, hemophilia A and thyroid disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SernovaCanada Flag
    Country
    Country
    Canada
    Address
    Address
    700 Collip Circle, Ste 114 London, ON, Canada N6G 4X8
    Telephone
    Telephone
    1.877.299.4603
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sernova.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/sernova-corp./
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/SernovaCorp/

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sernova, Eledon Collaborate for Potential Type 1 Diabetes Cure
    Sernova, Eledon Collaborate for Potential Type 1 Diabetes Cure

    09 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/09/3112555/0/en/Sernova-Biotherapeutics-Announces-Collaboration-with-Eledon-Pharmaceuticals-to-Advance-a-Potential-Functional-Cure-for-Type-1-Diabetes.html

    GLOBENEWSWIRE
    09 Jul 2025
    Share Share
    Sernova Appoints Jonathan Rigby as Interim Chair
    Sernova Appoints Jonathan Rigby as Interim Chair

    02 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/02/3092343/0/en/Sernova-Appoints-Jonathan-Rigby-as-Interim-Chair.html

    GLOBENEWSWIRE
    02 Jun 2025
    Share Share
    Chair of Sernova Biotherapeutics Resigns
    Chair of Sernova Biotherapeutics Resigns

    26 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/26/3087880/0/en/Chair-of-Sernova-Biotherapeutics-Resigns.html

    GLOBENEWSWIRE
    26 May 2025
    Share Share
    Sernova Forms Expert Board to Back Type 1 Diabetes Therapy
    Sernova Forms Expert Board to Back Type 1 Diabetes Therapy

    22 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/22/3086469/0/en/Sernova-Biotherapeutics-Appoints-World-Class-Clinical-Advisory-Board-to-Support-Development-of-Cell-Pouch-Bio-hybrid-Organ-as-Functional-Cure-for-Type-1-Diabetes.html

    GLOBENEWSWIRE
    22 May 2025
    Share Share
    Sernova Shares Interim Cell Pouch Data in Type 1 Diabetes Trial
    Sernova Shares Interim Cell Pouch Data in Type 1 Diabetes Trial

    14 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/14/3080975/0/en/Sernova-Biotherapeutics-Provides-Positive-Interim-Data-from-Ongoing-Phase-1-2-Clinical-Trial-of-Cell-Pouch-Bio-hybrid-Organ-in-Patients-Living-with-Type-1-Diabetes.html

    GLOBENEWSWIRE
    14 May 2025
    Share Share
    Sernova Biotherapeutics Secures $4M Loan for Clinical Development
    Sernova Biotherapeutics Secures $4M Loan for Clinical Development

    17 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/17/3063346/0/en/Sernova-Biotherapeutics-Secures-4-Million-Loan-to-Further-Advance-its-Clinical-Development-Plans.html

    GLOBENEWSWIRE
    17 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search